Quest Diagnostics Acquires ReproSource

We represented Quest Diagnostics (NYSE: DGX) in its acquisition of ReproSource, a Massachusetts-based provider of specialty fertility diagnostic services. Terms of the transaction were not disclosed.

Quest Diagnostics is the world’s leading provider of diagnostic information services. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States.

You Also May Be Interested In: